Mingjiang Xu Selected Research

Ethanol (Ethyl Alcohol)

1/2020	Chronic-plus-binge alcohol intake induces production of proinflammatory mtDNA-enriched extracellular vesicles and steatohepatitis via ASK1/p38MAPKα-dependent mechanisms.
1/2019	Alcohol inhibits T-cell glucose metabolism and hepatitis in ALDH2-deficient mice and humans: roles of acetaldehyde and glucocorticoids.
5/2014	Animals models of gastrointestinal and liver diseases. Animal models of alcohol-induced liver disease: pathophysiology, translational relevance, and challenges.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mingjiang Xu Research Topics

Disease

15	Neoplasms (Cancer) 10/2021 - 02/2007
11	Leukemia 01/2022 - 07/2013
10	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2022 - 04/2015
8	Primary Myelofibrosis (Myelosclerosis) 12/2010 - 06/2005
6	Inflammation (Inflammations) 09/2021 - 04/2013
6	Polycythemia Vera 11/2010 - 02/2007
4	Fibrosis (Cirrhosis) 01/2021 - 09/2014
3	Hepatitis 09/2021 - 01/2019
3	Bacterial Infections (Bacterial Infection) 01/2021 - 10/2018
3	Fatty Liver 01/2020 - 05/2014
3	Insulin Resistance 01/2015 - 11/2012
2	Body Weight (Weight, Body) 09/2021 - 01/2021
2	Dyslipidemias (Dyslipidemia) 09/2021 - 11/2012
2	Infections 01/2021 - 10/2018
2	Hyperglycemia 01/2021 - 11/2012
2	Hematologic Neoplasms (Hematological Malignancy) 01/2020 - 06/2015
2	Obesity 01/2015 - 11/2012
2	Myeloproliferative Disorders (Myeloproliferative Disorder) 12/2014 - 02/2007
2	Alcoholic Hepatitis 11/2014 - 09/2014
2	Alcoholic Liver Diseases (Alcoholic Liver Disease) 09/2014 - 05/2014
2	Pseudarthrosis (Pseudoarthrosis) 12/2013 - 12/2013
2	Osteoporosis 12/2013 - 01/2012
2	Splenomegaly 10/2011 - 05/2008
2	Hyperplasia 05/2008 - 08/2007
1	Liver Cirrhosis (Hepatic Cirrhosis) 09/2021
1	Non-alcoholic Fatty Liver Disease 09/2021
1	Liver Diseases (Liver Disease) 01/2021
1	Communicable Diseases (Infectious Diseases) 03/2020
1	Immune System Diseases (Immune Disorders) 03/2020
1	Alcoholic Fatty Liver 01/2020
1	Binge Drinking 01/2019
1	End Stage Liver Disease 10/2018
1	Hypersensitivity (Allergy) 01/2018
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 09/2017
1	Heart Failure 10/2015

Drug/Important Bio-Agent (IBA)

7	ChromatinIBA 01/2022 - 07/2007
7	Proteins (Proteins, Gene)FDA Link 01/2020 - 07/2013
6	Pharmaceutical PreparationsIBA 09/2021 - 02/2007
5	CytokinesIBA 01/2021 - 04/2013
4	Glucose (Dextrose)FDA LinkGeneric 01/2019 - 11/2012
3	Concanavalin AIBA 01/2021 - 01/2015
3	Interleukin-22 (IL-22)IBA 01/2021 - 09/2014
3	Transcription Factors (Transcription Factor)IBA 03/2020 - 11/2018
3	Phosphotransferases (Kinase)IBA 01/2020 - 12/2013
3	Ethanol (Ethyl Alcohol)IBA 01/2020 - 05/2014
3	EnzymesIBA 11/2018 - 09/2009
2	Long Noncoding RNAIBA 01/2022 - 01/2021
2	Interleukin-6 (Interleukin 6)IBA 01/2021 - 01/2021
2	RNA (Ribonucleic Acid)IBA 01/2020 - 01/2008
2	Ascorbic Acid (Vitamin C)FDA LinkGeneric 01/2020 - 09/2017
2	ChemokinesIBA 10/2019 - 11/2014
2	5-hydroxymethylcytosineIBA 09/2017 - 07/2013
2	TOR Serine-Threonine KinasesIBA 04/2016 - 12/2014
2	Biological ProductsIBA 10/2011 - 08/2007
2	AntioxidantsIBA 09/2009 - 01/2008
2	Thrombopoietin (c-mpl Ligand)IBA 05/2008 - 08/2007
2	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 11/2007 - 08/2007
1	AcetyltransferasesIBA 10/2021
1	bicyclolIBA 09/2021
1	NucleophosminIBA 01/2021
1	Nuclear Proteins (Protein, Nuclear)IBA 01/2021
1	Blood Glucose (Blood Sugar)IBA 01/2021
1	Cyclin-Dependent Kinase 9IBA 01/2021
1	interleukin 20 (IL-20)IBA 01/2021
1	InterleukinsIBA 01/2021
1	Core Binding Factor Alpha 2 SubunitIBA 03/2020
1	Proteolysis Targeting ChimeraIBA 01/2020
1	Mitochondrial DNA (mtDNA)IBA 01/2020
1	Histone Deacetylase InhibitorsIBA 01/2020
1	MAP Kinase Kinase Kinase 5IBA 01/2020
1	p38 Mitogen-Activated Protein KinasesIBA 01/2020
1	Ligases (Synthetase)IBA 01/2020
1	SirtuinsIBA 01/2020
1	Lysine (L-Lysine)FDA Link 01/2020
1	Oxidoreductases (Dehydrogenase)IBA 01/2020
1	Messenger RNA (mRNA)IBA 10/2019
1	AcetaldehydeIBA 01/2019
1	GlucocorticoidsIBA 01/2019
1	Hydrocortisone (Cortisol)FDA LinkGeneric 01/2019
1	CorticosteroneIBA 01/2019
1	coactivator-associated arginine methyltransferase 1IBA 11/2018
1	MethyltransferasesIBA 11/2018
1	Arginine (L-Arginine)FDA Link 11/2018
1	Lipocalin-2IBA 10/2018
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2018
1	Histones (Histone)IBA 01/2018
1	alpha-hydroxyglutarateIBA 01/2018
1	A-Form DNA (A-DNA)IBA 09/2017
1	DioxygenasesIBA 09/2017
1	DNA (Deoxyribonucleic Acid)IBA 09/2017
1	Caspase 3 (Caspase-3)IBA 01/2017
1	Tyrosine Kinase InhibitorsIBA 01/2017
1	Oncogene Proteins (Oncogene Protein)IBA 01/2017
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 04/2016
1	Mechanistic Target of Rapamycin Complex 1IBA 04/2016
1	Proto-Oncogene Proteins c-akt (Protein Kinase B)IBA 04/2016
1	Therapeutic UsesIBA 04/2016

Therapy/Procedure

9	Therapeutics 01/2021 - 06/2010
1	Intraperitoneal Injections 10/2018
1	Radiotherapy 01/2018